Healthequity (HQY) Net Equity Issued and Repurchased (2019 - 2022)

Healthequity's Net Equity Issued and Repurchased history runs 4 years deep, the most recent figure standing at -$2000.0 for Q1 2022.

• On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to -$2000.0 in Q1 2022; TTM through Oct 2022 was -$2000.0, a 100.0% decrease from a year earlier, with the FY2022 full-year figure at $456.6 million, up 59.23% from the prior year.
• Net Equity Issued and Repurchased retreated to -$2000.0 in Q1 2022 per HQY's latest filing, from $456.6 million in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $456.6 million in Q2 2021 and bottomed at -$539000.0 in Q4 2020.
• The 4-year median for Net Equity Issued and Repurchased is -$2000.0 (2022), against an average of $148.6 million.
• Biggest YoY gain for Net Equity Issued and Repurchased was 39.64% in 2020; the steepest drop was 39.64% in 2020.
• Year by year, Net Equity Issued and Repurchased stood at -$386000.0 in 2019, then plunged by 39.64% to -$539000.0 in 2020, then soared by 84820.22% to $456.6 million in 2021, then sank by 100.0% to -$2000.0 in 2022.
• Per Business Quant, the three latest HQY Net Equity Issued and Repurchased figures stand at -$2000.0 (Q1 2022), $456.6 million (Q2 2021), and -$539000.0 (Q4 2020).